Table 2 Genes associated with PD and depression identified from secondary analyses: Functional relevance and potential links to α-synuclein pathology
From: α-synuclein in Parkinson’s disease: a central point of convergence with depression
Gene | Molecular function | Evidence in PD | Evidence in depression | Potential interaction with α-syn |
|---|---|---|---|---|
Shared differentially expressed genes between PD (patients who differentially expressed SNCA) and MDD | ||||
MAP3K/ASK1 | The ASK1/MKK/JNK signalling pathway regulates apoptosis. | Overexpression of α-syn activated ASK1119. Deletion of ASK1 resulted in decreased phosphorylation, aggregation and propagation of α-syn, reduced nigrostriatal pathway degeneration105. | Suppression of ASK1 rescued rats from depressive behaviours106. | α-syn in pathological conditions uses ASK1 as a mediator to exert neurodegenerative effects. ASK1 in turn may be supportive of pathological changes to α-syn under stress. |
CARD8 | Inflammasome gene that promotes pyroptosis and inflammation upon activation. | N/A | Functional inactivation of CARD8 by polymorphism (rs2043211) was associated with higher anxiety scores amongst abstinent alcohol-dependent participants120. | There is no direct link between α-syn and CARD8 yet. It can be hypothesized that cell-stress induced by α-syn aggregates may be sensed by CARD8, triggering cell death and inflammation. |
GRB2 | GRB2 is an adaptor protein that notably mediates MAPK pathways, hence crucial for cell survival and cell proliferation (particularly important for immune cell response). | Cardiolipin response was augmented by virtue of the GRB2-TRKA-EVI1-CRLS1 axis, resulting in improved mitophagy, unfolded protein response and motor symptoms in PD121. | GRB2 identified as a “hub gene” from secondary analysis on three transcriptomic datasets of patients with depression. It was upregulated in hippocampi of rats with simulated depression122. | There is no direct link between α-syn and GRB2 yet. But, it can be hypothesized that α-syn aggregates upsets the mediatory role of GRB2 by interfering with downstream signalling pathways that determine cell survival and inflammation. |
RTN3 | Impairs clearance of cytosolic protein, promotes ER stress and apoptosis. | RTN3 was upregulated in transcriptome of PD patients123. It was also found in Lewy Bodies in post-mortem tissues124. | N/A | RTN3 appears to work in concert with α-syn pathology to prevent clearing up of accumulated protein and promote neurodegeneration. |
SP100 | Interferon response gene upregulated by interferons. | SP100 can bind to N-terminus of α-syn and leads to its aggregation in presence of Calcium107. | Upregulation of SP100 was associated with depressive symptoms in HIV+ men108. | The interaction between SP100 and α-syn needs to be studied mechanistically under pathological conditions. Based on current literature it can by hypothesized that SP100 may promote aggregation of α-syn under pathological imbalances. SP100 may further contribute to disease exacerbation by supporting inflammation and α-syn aggregation. |
TMEM127 | Regulator of mTORC. mTORC controls autophagy and cell survival. | Mutations in members of TMEM gene family were associated with early-onset PD125. | N/A | Disruptions to autophagy may lead to accumulation of α-syn. |
IRF2BPL | Regulates inflammatory responses in various cell types. | N/A | Coactivator of GR and NFκB126. | IRF2BPL coactivates GR. GR transactivates SNCA. NFκB led neuroinflammation can lead to accumulation of α-syn. |
Overlapping genes from GWAS on PD (cohorts reporting SNCA SNPs) and MDD | ||||
DYRK1A | Kinase activity implicated in multiple neurodegenerative diseases. | DYRK1A phosphorylates α-syn.Silencing DYRK1A rescued DA neurons from apoptosis and lowered p-α-syn102. Genetic variation in DYRK1A was associated to increased risk of PD127. DYRK1A promoted survival of DA neurons after MPTP128. | DYRK1A overexpression led to serotonin and dopamine deficit in parts of the brain103. | DYRK1A’s kinase activity promotes α-syn pathology. Simultaneously, it contributes to disease exacerbation and progression due to increased cell death of motor and serotonergic neurons. The α-syn pathology must contribute to this accompanying neurotoxicity. |
HLA-DRB1 | HLA class II molecules are present on antigen presenting cells. They are responsible for T-cell activation. VDR pathway: HLA-DRB1 has VDR-element in its promoter region. High risk HLA-DQA1 allele is associated with pro-inflammatory profiles and reduced responsiveness to Vitamin D109. | HLA-DRB1*15:01 allele transported normal and conformationally abnormal α-synuclein to the cell surface and extracellular vesicles129. The α-syn32-46 epitope binds to HLA-DRB1∗15:01 allele. This interaction triggers innate and adaptive immune gene signatures in the gut104. Certain polymorphisms in HLA-DRB1 are protective against PD110. | The HLA-DRB1*07:01 allele was associated with anxiety130. | The HLA molecules sensitize T-cells against α-syn and mediate an inflammatory environment necessary to mount an immune response. However, chronic inflammation in the brain is neurotoxic and may correlate with exacerbated disease symptoms. |
HLA-DQA1 | Higher DQA1 allele frequency was associated with PD susceptibility111. | Meta-analysis of 27 studies reported increased immune cells in depression, including CD4+ and CD8 + T-cells131. | ||